Latest Funds From Operations News

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Civmec Limited has reported a robust first half for FY26, with strong revenue growth, a record order book, and significant progress in naval shipbuilding. The company’s diversified operations and strategic contracts position it well for future growth.

Dexus Industria REIT (DXI) reported robust half-year results with 7.4% like-for-like income growth and near full occupancy, upgrading its FY26 FFO guidance. The REIT is actively recycling capital and progressing a $225 million development pipeline focused on high-quality industrial assets.

Dexus Industria REIT has slightly upgraded its FY26 funds from operations guidance, driven by robust portfolio income growth and strategic acquisitions in key industrial hubs. The REIT’s active management and development pipeline underpin its confidence in delivering secure, growing income.

Dexus Industria REIT reported a 19.3% drop in net profit for H1 FY26 but edged up its full-year FFO guidance, underpinned by strong leasing and a robust development pipeline.

Centuria Industrial REIT (ASX – CIP) reported a robust HY26 with strong income growth, portfolio valuation gains, and an upgraded full-year earnings forecast, underpinned by active leasing and strategic capital management.

Centuria Industrial REIT has reported robust HY26 financial results, underpinned by solid leasing activity, a $75 million valuation gain, and strategic expansion into the booming data centre sector. The REIT reaffirmed its FY26 guidance, signalling confidence in continued earnings growth amid favourable industrial market conditions.

Centuria Industrial REIT has reported a strong first half for 2025, with total revenue surging over 20% and net profit rising by 10%, while distributions remain steady.

Encounter Resources is set to launch a major 2026 exploration program at its Jessica Copper Project in the Northern Territory, partnering with South32 to test multiple high-potential copper targets identified through recent geophysical surveys.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.

AGL Energy reported a 42% drop in statutory profit for the half-year ended December 2025, despite a modest revenue decline and growth in customer services. The company declared a higher interim dividend, underscoring confidence amid operational challenges and a strategic pivot to renewables.

HomeCo Daily Needs REIT delivered consistent earnings growth in 1H FY26, underpinned by strong operational execution and disciplined capital management. The REIT reaffirmed its FY26 guidance while progressing a substantial development pipeline valued at over $650 million.